期刊文献+

GLP-1受体激动剂利拉鲁肽对2型糖尿病患者结肠镜检查肠道准备质量的影响 预览

Effect of GLP-1 receptor agonist liraglutide on the quality of bowel preparation for colonoscopy in patients with type 2 diabetes
在线阅读 下载PDF
分享 导出
摘要 目的:探讨人胰升糖素样肽1(glucagonlike peptide-1,GLP-1)受体激动剂利拉鲁肽对2型糖尿病患者结肠镜检查肠道准备质量的影响。方法:前瞻性纳入2014年11月至2017年10月首次行结肠镜检查且接受口服降糖药物联用利拉鲁肽或胰岛素治疗的2型糖尿病患者195例,以聚乙二醇电解质散4L分次口服方案进行肠道准备,采用渥太华肠道准备评分量表(Ottawa Bowel Preparation Scale,OBPS)和肠道准备满意度(OBPS评分≤6分)比例评估肠道准备质量。结果:口服降糖药物联用利拉鲁肽(利拉鲁肽组)87例,联用胰岛素(胰岛素组)108例,2组基线资料具有可比性(P〉0.05)。利拉鲁肽组和胰岛素组OBPS评分相似(5.86±1.74 vs 5.54±1.81,t=1.270,P=0.206),肠道准备满意率相似(81.6% vs 82.4%,χ^2=0.021,P=0.885)。2组肠道准备期间均未见低血糖事件发生。结论:GLP-1受体激动剂利拉鲁肽对2型糖尿病患者结肠镜检查肠道准备质量的影响较小。 Objective: To evaluate the effect of glucagonlike peptide-1 (GLP-1) receptor agonist liraglutide on the quality of bowel preparation for colonoscopy in patients with type 2 diabetes. Methods: A series of 195 patients with type 2 diabetes mellitus received oral hypoglycemic drugs combined liraglutide or insulin and underwent the first colonoscopy were prospectively enrolled from November 2014 to October 2017. The same split-dose 4 L polyethylene glycol was used for bowel cleansing. The Ottawa Bowel Preparation Scale (OBPS) and satisfactory bowel preparation (OBPS score of 6 or less) were used to assess the quality of bowel preparation. Results: In this series, 87 patients accepted oral hypoglycemic drugs combined liraglutide (the liraglutide group), and 108 patients accepted oral hypoglycemic drugs combined with insulin (the insulin group). The baseline data of the 2 groups were comparable (P〉0.05). The OBPS scores (5.86±1.74 vs 5.54±1.81, t=1.270, P=0.206), and the satisfaction bowel preparation rate were similar (81.6% vs 82.4%, χ^2=0.021, P=0.885) between the liraglutide group and the insulin groups (P〉0.05). There were no hypoglycemic events in the 2 groups during the bowel preparation. Conclusion: The GLP-1 receptor agonist liraglutide has little effect on the quality of bowel preparation for colonoscopy in patients with diabetes mellitus. Keywords: GLP-1 receptor agonist; liraglutide; diabetes mellitus; colonoscopy; bowel preparatio
作者 陈小芳 于西全 陈威 吴锐枫 陈秀芳 CHEN Xiaofang, YU Xiquan, CHEN Wei, WU Ruifeng, CHEN Xiufang (Department of Pharmacy, Fuzhou General Hospital of People's Liberation Army, Fuzhou 350025, China.)
出处 《临床与病理杂志》 2018年第4期743-746,共4页 Journal of International Pathology and Clinical Medicine
基金 福建省科技计划重大项目(201211001).
关键词 GLP-1受体激动剂 利拉鲁肽 糖尿病 结肠镜检查 肠道准备 GLP-1 receptor agonist liraglutide diabetes mellitus colonoscopy bowel preparation
作者简介 通信作者:陈小芳,Email:wrf_2016@qq.com
  • 相关文献
投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈